Swift Energy Co (SFY)

0.14
0.00 (0.00)
OTC : Basic Materials
Prev Close 0.14
Open 0.14
Day Low/High 0.12 / 0.16
52 Wk Low/High 0.03 / 3.47
Volume 563.56K
Avg Volume 564.50K
Exchange OTC
Shares Outstanding 44.55M
Market Cap 7.05M
EPS -6.47
Div & Yield N.A. (N.A)

Latest News

Synchrony Financial Hikes Dividend, Announces $1.64 Billion Share Buyback Program

Synchrony Financial Hikes Dividend, Announces $1.64 Billion Share Buyback Program

Synchrony now has a 15 cent per share dividend.

Stock Futures Creep Higher as D.C. Grows Quiet After Week of Bombshells

Stock Futures Creep Higher as D.C. Grows Quiet After Week of Bombshells

Stock futures creep higher on Friday in a quieter end to the week after a series of bombshells rock the White House.

EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks

EpiPen Competitor Auvi-Q Will Return in February, but It'll Cost Insurance Companies Big Bucks

The autoinjector will be free for insured patients and those whose annual income is less than $100,000.

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.

Kaleo CEO Positive on EpiPen Competition

Kaleo CEO Positive on EpiPen Competition

A more affordable competitor to Mylan's MYL EpiPen is set to enter the market earlier than expected, and will likely pose a threat to the autoinjector's dominance in the space.

Mylan Falls on News of the Return of Auvi-Q

Mylan Falls on News of the Return of Auvi-Q

A competitor to Mylan's MYL autoinjector, EpiPen, will hit the market sooner than expected thanks to a private pharmaceutical company, Kaleo Pharmaceuticals.

Big Pharma Spends Millions to Keep Prices High for California Agencies

Big Pharma Spends Millions to Keep Prices High for California Agencies

Drug companies like Merck, Pfizer and Johnson & Johnson are spending big bucks on the opposition of Proposition 61.

Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem

Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem

The pharmaceutical company announced that it will increase its patient assistance program in hopes of quelling a growing backlash over its drug pricing.

Why EpiPen, Why Now? Analysts Explain the Timing of Mylan's Trouble

Why EpiPen, Why Now? Analysts Explain the Timing of Mylan's Trouble

The pharma company has been increasing the price of the epinephrine injector since 2007, so why are people finally taking notice?

A Backlash Materializes Against Soaring EpiPen Prices

A Backlash Materializes Against Soaring EpiPen Prices

Senators Grassley, Blumenthal and Klobuchar demand Mylan reduce the price of its dominant treatment for life-threatening allergies.

Mylan's Time Leaning on EpiPens Is Rapidly Approaching an End

Mylan's Time Leaning on EpiPens Is Rapidly Approaching an End

The Pittsburgh-based pharmaceutical company has been steadily jacking up the price of the auto injectors since 2010 to bolster revenues.

Valeant's Share Price Tumbles, Even as Papa Reiterates Plans for Divestitures

Valeant's Share Price Tumbles, Even as Papa Reiterates Plans for Divestitures

Some analysts say the company could be worth a second look, though, as they expect top line growth.

2 Promising Biopharmas Reach Key Junctures

FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.

Wall Street's Energy Loans Suffer Frostbite From Warm Winter

Wall Street's Energy Loans Suffer Frostbite From Warm Winter

Oil prices below $40 means more energy companies are likely to default on loans from big Wall Street banks such as JPMorgan, Citigroup and Bank of America.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are poised to move higher from current levels.

Swift Energy Elects Not To Make Senior Notes Interest Payment And Continues Negotiations With Bondholder Group

Swift Energy Elects Not To Make Senior Notes Interest Payment And Continues Negotiations With Bondholder Group

Swift Energy Company (NYSE: SFY) ("Swift Energy" or the "Company") today announced that, although it has current liquidity sufficient to make the $8.

Swift Energy Adopts Right Plan To Protect Net Operating Loss Carryforwards

Swift Energy Adopts Right Plan To Protect Net Operating Loss Carryforwards

Swift Energy Company (NYSE:SFY) ("Swift Energy" or the "Company") announced today that its Board of Directors (the "Board") has adopted a net operating loss ("NOL") rights plan (the "Rights Plan") in an effort to prevent...

Swift Energy Announces Third Quarter 2015 Results

Swift Energy Announces Third Quarter 2015 Results

Swift Energy Company (NYSE:SFY) reported today its third quarter 2015 financial and operating results.

Swift Energy Announces Third Quarter 2015 Earnings Release And Conference Call

Swift Energy Announces Third Quarter 2015 Earnings Release And Conference Call

Swift Energy Company (NYSE: SFY) will report its third quarter financial results on Thursday, November 5, 2015 by issuing a news release before the market opens and conducting a conference call to discuss such results on...

How Many More Oil & Gas Companies Will File for Bankruptcy?

How Many More Oil & Gas Companies Will File for Bankruptcy?

An increasing number of energy companies are likely to file for Chapter 11, if oil prices stay low, capital markets dry up and the banks cut back on lending.

Swift Energy Receives Continued Listing Standard Notice From NYSE

Swift Energy Receives Continued Listing Standard Notice From NYSE

Swift Energy Company (NYSE: SFY) announced that on August 14, 2015, the New York Stock Exchange (the "NYSE") notified the Company that it is not in compliance with the continued listing standards set forth in Sections 802.

Swift Energy Announces Second Quarter 2015 Results

Swift Energy Announces Second Quarter 2015 Results

Swift Energy Company (NYSE: SFY) reported today its second quarter 2015 financial and operating results.

Swift Energy Retains Lazard To Advise As To Strategic Alternatives Related To Its Capital Structure

Swift Energy Retains Lazard To Advise As To Strategic Alternatives Related To Its Capital Structure

Swift Energy Company (NYSE: SFY) announced today that it has retained Lazard Freres & Co.

Trade-Ideas: Swift Energy (SFY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Swift Energy (SFY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Swift Energy (SFY) as a weak on high relative volume candidate

Swift Energy (SFY) Stock Downgraded at KeyBanc

Swift Energy (SFY) Stock Downgraded at KeyBanc

KeyBanc downgraded Swift Energy (SFY) stock to ‘sector weight’ from ‘overweight.’

Analysts' Actions -- Boeing, Biogen, Comcast and More

Analysts' Actions -- Boeing, Biogen, Comcast and More

Here are Tuesday's top research calls, including new coverage of Boeing and Comcast.

Strong On High Relative Volume: Swift Energy (SFY)

Strong On High Relative Volume: Swift Energy (SFY)

Trade-Ideas LLC identified Swift Energy (SFY) as a strong on high relative volume candidate

Swift Energy Announces Second Quarter 2015 Earnings Release And Conference Call

Swift Energy Announces Second Quarter 2015 Earnings Release And Conference Call

Swift Energy Company (NYSE: SFY) will report its second quarter financial results on Thursday, August 6, 2015 by issuing a news release before the market opens and conducting a conference call to discuss such results on...